VRDN Viridian Therapeutics, Inc.\DE
Healthcare · Market cap: $3.5B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $1.1M |
| 2022-Q2 | $0 | $1.3M |
| 2022-Q3 | $10.0M | $0 |
| 2022-Q4 | $0 | $1.2M |
| 2023-Q1 | $160.3K | $6.1M |
| 2023-Q2 | $101.5K | $250.5K |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $10.0M | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $30.6M | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $10.0M | $70.8K |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $20.0M | $0 |
| 2026-Q3 | $0 | $348.2K |
| 2026-Q4 | $0 | $0 |
Bought$80.9M9 buy days
Sold$10.4M30 sell days
Net insider flow+$70.5Mnet buying · 5 years
Latest trade2026-08-19Tousignant Jennifer
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | Sell | Tousignant Jennifer | Other C-suite | 14,212 | $24.50 | $348.2K | 2 |
| 2026-05-11 | Buy | Fairmount Healthcare Fund II L.P. | Director | 1,176,470 | $17.00 | $20.0M | 1 |
| 2025-12-31 | Sell | Tousignant Jennifer | Other C-suite | 2,272 | $31.16 | $70.8K | 1 |
| 2025-10-23 | Buy | Fairmount Healthcare Fund II L.P. | Director | 454,545 | $22.00 | $10.0M | 1 |
| 2024-09-27 | Buy | Mahoney Stephen F. | CEO | 21,400 | $23.33 | $499.3K | 1 |
| 2024-09-27 | Buy | Beetham Thomas W. | COO | 5,000 | $23.41 | $117.0K | 1 |
| 2024-09-13 | Buy | Fairmount Healthcare Fund II L.P. | Director | 1,600,000 | $18.75 | $30.0M | 1 |
| 2024-01-22 | Buy | Fairmount Healthcare Fund L.P. | Director | 476,190 | $21.00 | $10.0M | 1 |
| 2023-06-16 | Sell | Meisner Lara | Other C-suite | 27 | $28.35 | $765 | 1 |
| 2023-06-15 | Sell | Meisner Lara | Other C-suite | 2,269 | $28.02 | $63.6K | 1 |
| 2023-06-06 | Sell | Meisner Lara | Other C-suite | 5,126 | $25.02 | $128.3K | 1 |
| 2023-06-05 | Sell | Meisner Lara | Other C-suite | 499 | $25.03 | $12.5K | 1 |
| 2023-06-02 | Sell | Meisner Lara | Other C-suite | 1,875 | $24.21 | $45.4K | 1 |
| 2023-04-12 | Buy | Myers Scott Dunseth | CEO | 4,000 | $25.37 | $101.5K | 1 |
| 2023-03-13 | Buy | Myers Scott Dunseth | CEO | 5,500 | $29.15 | $160.3K | 1 |
| 2023-03-09 | Sell | Meisner Lara | General counsel | 29,971 | $29.07 | $871.3K | 1 |
| 2023-02-02 | Sell | Violin Jonathan | Other C-suite | 50,000 | $36.80 | $1.8M | 1 |
| 2023-01-23 | Sell | Meisner Lara | General counsel | 6,843 | $35.66 | $244.0K | 1 |
| 2023-01-17 | Sell | Katz Barrett | Other C-suite | 24,853 | $37.21 | $924.8K | 1 |
| 2023-01-13 | Sell | Katz Barrett | Other C-suite | 4,147 | $37.01 | $153.5K | 1 |
| 2023-01-10 | Sell | Katz Barrett | Other C-suite | 47,377 | $35.30 | $1.7M | 1 |
| 2023-01-09 | Sell | Katz Barrett | Other C-suite | 12,623 | $33.04 | $417.1K | 1 |
| 2022-12-21 | Sell | Meisner Lara | General counsel | 16,326 | $29.19 | $476.6K | 1 |
| 2022-12-20 | Sell | Meisner Lara | General counsel | 600 | $28.07 | $16.8K | 1 |
| 2022-12-16 | Sell | Meisner Lara | General counsel | 1,297 | $28.44 | $36.9K | 1 |
| 2022-12-15 | Sell | Meisner Lara | General counsel | 300 | $28.08 | $8.4K | 1 |
| 2022-12-14 | Sell | Meisner Lara | General counsel | 15,656 | $28.12 | $440.2K | 1 |
| 2022-12-12 | Sell | Meisner Lara | General counsel | 600 | $28.05 | $16.8K | 1 |
| 2022-11-15 | Sell | Meisner Lara | General counsel | 8,125 | $22.05 | $179.2K | 1 |
| 2022-08-17 | Buy | Fairmount Healthcare Fund L.P. | Director | 425,531 | $23.50 | $10.0M | 1 |
| 2022-06-01 | Sell | Violin Jonathan | Other C-suite | 30,000 | $12.20 | $366.0K | 1 |
| 2022-05-02 | Sell | Violin Jonathan | CEO | 30,000 | $13.04 | $391.2K | 1 |
| 2022-04-04 | Sell | Violin Jonathan | Other C-suite | 3,600 | $18.93 | $68.1K | 1 |
| 2022-04-01 | Sell | Violin Jonathan | Other C-suite | 26,400 | $18.92 | $499.5K | 1 |
| 2022-03-02 | Sell | Violin Jonathan | Other C-suite | 11,106 | $17.36 | $192.8K | 1 |
| 2022-03-01 | Sell | Violin Jonathan | Other C-suite | 18,894 | $17.82 | $336.7K | 1 |
| 2022-02-03 | Sell | Violin Jonathan | Other C-suite | 909 | $19.16 | $17.4K | 1 |
| 2022-02-02 | Sell | Violin Jonathan | Other C-suite | 12,340 | $18.47 | $227.9K | 1 |
| 2022-02-01 | Sell | Violin Jonathan | Other C-suite | 16,751 | $19.55 | $327.5K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Fairmount Healthcare Fund II L.P. | Director | $80.0M | $0 | 2026-05-11 |
| Violin Jonathan | Other C-suite | $0 | $4.3M | 2023-02-02 |
| Katz Barrett | Other C-suite | $0 | $3.2M | 2023-01-17 |
| Meisner Lara | Other C-suite | $0 | $2.5M | 2023-06-16 |
| Mahoney Stephen F. | CEO | $499.3K | $0 | 2024-09-27 |
| Tousignant Jennifer | Other C-suite | $0 | $419.0K | 2026-08-19 |
| Myers Scott Dunseth | CEO | $261.8K | $0 | 2023-04-12 |
| Beetham Thomas W. | COO | $117.0K | $0 | 2024-09-27 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-09-13 → 2024-09-27 | 3 | $30.6M | 63 | -9.9% (-9.3% raw) | -22.2% (-21.6% raw) | -34.8% (-48.2% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.